Renowned Harvard University geneticist David Sinclair recently made a startling assertion: Scientific data shows he has knocked more than two decades off his biological age.
Whats the 49-year-olds secret? He says his daily regimen includes ingesting a molecule his own research found improved the health and lengthened the life span of mice. Sinclair now boasts online that he has the lung capacity, cholesterol and blood pressure of a young adult and the heart rate of an athlete.
Despite his enthusiasm, published scientific research has not yet demonstrated the molecule works in humans as it does in mice. Sinclair, however, has a considerable financial stake in his claims being proven correct, and has lent his scientific prowess to commercializing possible life extension products such molecules known as NAD boosters.
His financial interests include being listed as an inventor on a patent licensed to Elysium Health, a supplement company that sells a NAD booster in pills for $60 a bottle. Hes also an investor in InsideTracker, the company that he says measured his age.
Discerning hype from reality in the longevity field has become tougher than ever as reputable scientists such as Sinclair and pre-eminent institutions like Harvard align themselves with promising but unproven interventions and at times promote and profit from them.
Fueling the excitement, investors pour billions of dollars into the field even as many of the products already on the market face fewer regulations and therefore a lower threshold of proof.
If you say youre a terrific scientist and you have a treatment for aging, it gets a lot of attention, said Jeffrey Flier, a former Harvard Medical School dean who has been critical of the hype. There is financial incentive and inducement to overpromise before all the research is in.
MELANIE MAXWELL FOR KHNMice frolic in Richard Millers pathology and geriatrics lab at the University of Michigan. Miller heads one of the three labs funded by NIH to test anti-aging substances on mice.
Elysium, co-founded in 2014 by a prominent MIT scientist to commercialize the molecule nicotinamide riboside, a type of NAD booster, highlights its exclusive licensing agreement with Harvard and the Mayo Clinic and Sinclairs role as an inventor. According to the companys press release, the agreement is aimed at supplements that slow aging and age-related diseases.
Further adding scientific gravitas to its brand, the website lists eight Nobel laureates and 19 other prominent scientists who sit on its scientific advisory board. The company also advertises research partnerships with Harvard and U.K. universities Cambridge and Oxford.
Some scientists and institutions have grown uneasy with such ties. Cambridges Milner Therapeutics Institute announced in 2017 it would receive funding from Elysium, cementing a research partnership. But after hearing complaints from faculty that the institute was associating itself with an unproven supplement, it quietly decided not to renew the funding or the companys membership to its innovation board.
The sale of nutritional supplements of unproven clinical benefit is commonplace, said Stephen ORahilly, the director of Cambridges Metabolic Research Laboratories who applauded his university for reassessing the arrangement. What is unusual in this case is the extent to which institutions and individuals from the highest levels of the academy have been co-opted to provide scientific credibility for a product whose benefits to human health are unproven.
The promise
A generation ago, scientists often ignored or debunked claims of a fountain of youth pill.
Until about the early 1990s, it was kind of laughable that you could develop a pill that would slow aging, said Richard Miller, a biogerontologist at the University of Michigan who heads one of three labs funded by the National Institutes of Health to test such promising substances on mice. It was sort of a science fiction trope. Recent research has shown that pessimism is wrong.
Mice given molecules such as rapamycin live as much as 20 percent longer. Other substances such as 17 alpha estradiol and the diabetes drug Acarbose have been shown to be just as effective in mouse studies. Not only do mice live longer, but, depending on the substance, they avoid cancers, heart ailments and cognitive problems.
(MELANIE MAXWELL FOR KHN)Until about the early 1990s, it was kind of laughable that you could develop a pill that would slow aging, says University of Michigan biogerontologist Richard Miller. It was sort of a science fiction trope. Recent research has shown that pessimism is wrong.
But human metabolism is different from that of rodents. And our existence is unlike a mouses life in a cage. What is theoretically possible in the future remains unproven in humans and not ready for sale, experts say.
History is replete with examples of cures that worked on mice but not in people. Multiple drugs, for instance, have been effective at targeting an Alzheimers-like disease in mice yet have failed in humans.
None of this is ready for prime time. The bottom line is I dont try any of these things, said Felipe Sierra, the director of the division of aging biology at the National Institute on Aging at NIH. Why dont I? Because Im not a mouse.
The hype
Concerns about whether animal research could translate into human therapy have not stopped scientists from racing into the market, launching startups or lining up investors. Some true believers, including researchers and investors, are taking the substances themselves while promoting them as the next big thing in aging.
While the buzz encourages investment in worthwhile research, scientists should avoid hyping specific [substances], said S. Jay Olshansky, a professor who specializes in aging at the School of Public Health at the University of Illinois at Chicago.
Yet some scientific findings are exaggerated to help commercialize them before clinical trials in humans demonstrate both safety and efficacy, he said.
Its a great gig if you can convince people to send money and use it to pay exorbitant salaries and do it for 20 years and make claims for 10, Olshansky said. Youve lived the high life and get investors by whipping up excitement and saying the benefits will come sooner than they really are.
Promising findings in animal studies have stirred much of this enthusiasm.
Research by Sinclair and others helped spark interest in resveratrol, an ingredient in red wine, for its potential anti-aging properties. In 2004, Sinclair co-founded a company, Sirtris, to test resveratrols potential benefits and declared in an interview with the journal Science it was as close to a miraculous molecule as you can find. GlaxoSmithKline bought the company in 2008 for $720 million. By the time Glaxo halted the research in 2010 because of underwhelming results with possible side effects, Sinclair had already received $8 million from the sale, according to Securities and Exchange Commission documents. He also had earned $297,000 a year in consulting fees from the company, according to The Wall Street Journal.
At the height of the buzz, Sinclair accepted a paid position with Shaklee, which sold a product made out of resveratrol. But he resigned after The Wall Street Journal highlighted positive comments he made about the product that the company had posted online. He said he never gave Shaklee permission to use his statements for marketing.
Sinclair practices what he preaches or promotes. On his LinkedIn bio and in media interviews, he describes how he now regularly takes resveratrol; the diabetes drug metformin, which holds promise in slowing aging; and nicotinamide mononucleotide, a substance known as NMN that his own research showed rejuvenated mice.
Of that study, he said in a video produced by Harvard that it sets the stage for new medicines that will be able to restore blood flow in organs that have lost it, either through a heart attack, a stroke or even in patients with dementia.
In an interview with KHN, Sinclair said hes not recommending that others take those substances.
Im not claiming Im actually younger. Im just giving people the facts, he said, adding that hes sharing the test results from InsideTrackers blood tests, which calculate biological age based on biomarkers in the blood. They said I was 58, and then one or two blood tests later they said I was 31.4.
InsideTracker sells an online age-tracking package to consumers for up to about $600. The companys website highlights Sinclairs support for the company as a member of its scientific advisory board. It also touts a study that describes the benefits of such tracking, which Sinclair co-authored.
Sinclair is involved either as a founder, an investor, an equity holder, a consultant or a board member with 28 companies, according to a list of his financial interests. At least 18 are involved in anti-aging in some way, including studying or commercializing NAD boosters. The interests range from longevity research startups aimed at humans and even pets to developing a product for a French skin care company to advising a longevity investment fund. Hes also an inventor named in the patent licensed by Harvard and the Mayo Clinic to Elysium, and one of his companies, MetroBiotech, has filed a patent related to nicotinamide mononucleotide, which he says he takes himself.
Sinclair and Harvard declined to release details on how much money he or the university is generating from these disclosed outside financial interests. Sinclair estimated in a 2017 interview with Australias Financial Review that he raises $3 million a year to fund his Harvard lab.
Liberty Biosecurity, a company he co-founded, estimated in Sinclairs online bio that he has been involved in ventures that have attracted more than a billion dollars in investment. When KHN asked him to detail the characterization, he said it was inaccurate, without elaborating, and the comments later disappeared from the website.
Sinclair cited confidentiality agreements for not disclosing his earnings, but he added that most of this income has been reinvested into companies developing breakthrough medicines, used to help my lab, or donated to nonprofits. He said he did not know how much he stood to make off the Elysium patent, saying Harvard negotiated the agreement.
Harvard declined to release Sinclairs conflict-of-interest statements, which university policy requires faculty at the medical school to file in order to protect against any faculty bias that could heighten the risk of harm to human research participants or recipients of products resulting from such research.
We can only be proud of our collaborations if we can represent confidently that such relationships enhance, and do not detract from, the appropriateness and reliability of our work, the policy states.
Elysium advertises both Harvards and Sinclairs ties to its company. It was co-founded by Massachusetts Institute of Technology professor Leonard Guarente, Sinclairs former research adviser and an investor in Sinclairs Sirtris.
Echoing his earlier statements on resveratrol, Sinclair is quoted on Elysiums website as describing NAD boosters as one of the most important molecules for life.
Supplement loophole?
The Food and Drug Administration doesnt categorize aging as a disease, which means potential medicines aimed at longevity generally cant undergo traditional clinical trials aimed at testing their effects on human aging. In addition, the FDA does not require supplements to undergo the same safety or efficacy testing as pharmaceuticals.
The banner headline on Elysiums website said that clinical trial results prove safety and efficacy of its supplement, Basis, which contains the molecule nicotinamide riboside and pterostilbene. But the companys research did not demonstrate the supplement was effective at anti-aging in humans, as it may be in mice. It simply showed the pill increased the levels of the substance in blood cells.
Elysium is selling pills to people online with the assertion that the pills are clinically proven said ORahilly. Thus far, however the benefits and risks of this change in chemistry in humans is unknown.
Many interventions that seem sensible on the basis of research in animals turn out to have unexpected effects in man, he added, citing a large clinical trial of beta carotene that showed it increased rather than decreased the risk of lung cancer in smokers.
Elysiums own research documented a small but significant increase in cholesterol, but added more studies were needed to determine whether the changes were real or due to chance. One independent study has suggested that a component of NAD may influence the growth of some cancers, but researchers involved in the study warned it was too early to know.
Guarente, Elysiums co-founder and chief scientist, told KHN he isnt worried about any side effects from Basis, and he emphasized that his company is dedicated to conducting solid research. He said his company monitors customers safety reports and advises customers with health issues to consult with their doctors before using it.
If a substance meets the FDAs definition of a supplement and is advertised that way, then the agency cant take action unless it proves a danger, said Alta Charo, a former bioethics policy adviser to the Obama administration. Pharmaceuticals must demonstrate safety and efficacy before being marketed.
A lot of what goes on here is really, really careful phrasing for what you say the thing is for, said Charo, a law professor at the University of Wisconsin. If theyre marketing it as a cure for a disease, then they get in trouble with the FDA. If theyre marketing it as a rejuvenator, then the FDA is hamstrung until a danger to the public is proven.
This is a recipe for some really unfortunate problems down the road, Charo added. We may be lucky and it may turn out that a lot of this stuff turns out to be benignly useless. But for all we know, itll be dangerous.
The debate about the risks and benefits of substances that have yet to be proven to work in humans has triggered a debate over whether research institutions are scrutinizing the financial interests and involvement of their faculty or the institution itself closely enough. It remains to be seen whether Cambridges decision not to renew its partnership will prompt others to rethink such ties.
Flier, the former dean of Harvard Medical School, had earlier heard complaints and looked into the relationships between scientists and Elysium after he stepped down as dean. He said he discovered that many of the board members who allowed their names and pictures to be posted on the company website knew little about the scientific basis for use of the companys supplement.
Flier recalls that one scientist had no real role in advising the company and never attended a company meeting. Even so, Elysium was paying him for his role on the board, Flier said.
Caroline Perry, director of communications for Harvards Office of Technology Development, said agreements such as Harvards acceptance of research funds from Elysium comply with university policies and protect the traditional academic independence of the researchers.
Harvard enters into research agreements with corporate partners who express a commitment to advancing science by supporting research led by Harvard faculty, Perry added.
Like Harvard, the Mayo Clinic refused to release details on how much money it would make off the Elysium licensing agreement. Mayo and Harvard engaged in substantial diligence and extended negotiations before entering into the agreement, said a Mayo spokeswoman.
The company provided convincing proof that they are committed to developing products supported by scientific evidence, said the spokeswoman, Duska Anastasijevic.
Guarente of Elysium refused to say how much he or Elysium was earning off the sale of the supplement Basis. MIT would not release his conflict-of-interest statements.
Private investment funds, meanwhile, continue to pour into longevity research despite questions about whether the substances work in people.
One key Elysium investor is the Morningside Group, a private equity firm run by Harvards top donor, Gerald Chan, who also gave $350 million to the Harvard School of Public Health.
Billionaire and WeWork co-founder Adam Neumann has invested in Sinclairs Life Biosciences.
An investment firm led by engineer and physician Peter Diamandis gave a group of Harvard researchers $5.5 million for their startup company after their research was publicly challenged by several other scientists.
In its announcement of the seed money, the company, Elevian, said its goal was to develop new medicines that increase the activity levels of the hormone GDF11 to potentially prevent and treat age-related diseases.
It described research by its founders, which include Harvards Amy Wagers and Richard Lee, as demonstrating that replenishing a single circulating factor, GDF11, in old animals mirrors the effects of young blood, repairing the heart, brain, muscle and other tissues.
Other respected labs in the field have either failed to replicate or contradict key elements of their observations.
Elevians CEO, Mark Allen, said the early scientific data on GDF11 is encouraging, but drug discovery and development is a time-intensive, risky, regulated process requiring many years of research, preclinical [animal] studies, and human clinical trials to successfully bring new drugs to market.
Flier worries research in the longevity field could be compromised, although he recognizes the importance and promise of the science. He said hes concerned that alliances between billionaires and scientists could lead to less skepticism.
A susceptible billionaire meets a very good salesman scientist who looks him deeply in the eyes and says, Theres no reason why we cant have a therapy that will let you live 400 or 600 years, Flier said. The billionaire will look back and see someone who is at MIT or Harvard and say, Show me what you can do.
Despite concerns about the hype, scientists are hopeful of finding a way forward by relying on hard evidence. The consensus: A pill is on the horizon. Its just a matter of time and solid research.
If you want to make money, hiring a sales rep to push something that hasnt been tested is a really great strategy, said Miller, who is testing substances on mice. If instead you want to find drugs that work in people, you take a very different approach. It doesnt involve sales pitches. It involves the long, laborious, slogging process of actually doing research.
KHN senior correspondent Jay Hancock contributed to this report.
Kaiser Health News (KHN) is a nonprofit news service covering health issues. It is an editorially independent program of the Kaiser Family Foundation that is not affiliated with Kaiser Permanente.
Calling all HuffPost superfans!
Sign up for membership to become a founding member and help shape HuffPost's next chapter
Continued here:
A Harvard Geneticist Wants To Sell A Magical ... - HuffPost
- Scientists believe that aging might be optional - Mail Herald [Last Updated On: August 18th, 2024] [Originally Added On: November 18th, 2019]
- This Week in Running: November 18, 2019 - iRunFar [Last Updated On: August 18th, 2024] [Originally Added On: November 21st, 2019]
- Aging as a preventable disease and why living to 100 should be easy - Genetic Literacy Project [Last Updated On: August 18th, 2024] [Originally Added On: November 21st, 2019]
- David Sinclair on Joe Rogan Podcast - chatting about NMN and ... [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- NMN and NAD Reverse Aging of Blood Vessels in New Study [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- #70 - David Sinclair, Ph.D.: How cellular reprogramming could ... [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- Lifespan: Why We Age_and Why We Don't Have To: David A ... [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- David Sinclair supplements and protocol explained NMN ... [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- David Sinclair's biological age was 58 after taking 1000 mg ... [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- David Sinclairs anti-aging science | Harvard Magazine [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- David Sinclair Supplements For Anti-Aging - What He Takes & Why [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- What Does David Sinclair Eat and Supplement? (2019 ... [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- #27 - David Sinclair, Ph.D.: Slowing aging sirtuins, NAD ... [Last Updated On: August 18th, 2024] [Originally Added On: November 23rd, 2019]
- Man with string of convictions in his native Poland came to Perth to set up drug den - The Courier [Last Updated On: August 18th, 2024] [Originally Added On: November 30th, 2019]
- Last surviving Viking-inspired boat that served a now- abandoned island goes up for auction - The Scotsman [Last Updated On: August 18th, 2024] [Originally Added On: November 30th, 2019]
- Dealer Jailed After Raid Uncovers 44k of Grugs - Daily Record [Last Updated On: August 18th, 2024] [Originally Added On: November 30th, 2019]
- Lazarus Effect: Sixteen-year study by Dr. Leis resulted in recovery from West Nile for Dr. Bush - Northside Sun [Last Updated On: August 18th, 2024] [Originally Added On: December 21st, 2019]
- OZY Takes You Ahead of the Curve in Science and Technology - OZY [Last Updated On: August 18th, 2024] [Originally Added On: December 29th, 2019]
- The Race To Find A Cure For Aging - Medium [Last Updated On: August 18th, 2024] [Originally Added On: January 1st, 2020]
- Hard work and dedication honored - Union Daily Times [Last Updated On: August 18th, 2024] [Originally Added On: January 23rd, 2020]
- Meet the people who think soaking in a frozen Minneapolis lake is the secret to good health - Minneapolis Star Tribune [Last Updated On: August 18th, 2024] [Originally Added On: January 24th, 2020]
- BOYS SWIMMING: Tigersharks top Waconia in conference dual - Crow River Media [Last Updated On: August 18th, 2024] [Originally Added On: January 25th, 2020]
- David Sinclair on NMN and Epigenetics | | LEAF [Last Updated On: August 18th, 2024] [Originally Added On: January 25th, 2020]
- Brave Cashel Community School get the better of St Augustine's to set-up a Munster hurling final clash with Doon - TipperaryLive.ie [Last Updated On: August 18th, 2024] [Originally Added On: January 28th, 2020]
- Diane Francis: Treating aging like a disease is the next big thing for science - Financial Post [Last Updated On: August 18th, 2024] [Originally Added On: January 28th, 2020]
- Letter: Yes to Green Growth | Opinion - Southern Pines Pilot [Last Updated On: August 18th, 2024] [Originally Added On: January 28th, 2020]
- Kelty Hearts 4-1 Caledonian Braves: Third straight defeat for Braves - Motherwell Times [Last Updated On: August 18th, 2024] [Originally Added On: February 6th, 2020]
- Is soaking in a frozen lake the secret to good health? - The Detroit News [Last Updated On: August 18th, 2024] [Originally Added On: February 12th, 2020]
- Letter:Deputy Is Vindicated | Opinion - Southern Pines Pilot [Last Updated On: August 18th, 2024] [Originally Added On: February 12th, 2020]
- BOYS SWIMMING: Chargers take fifth at WCC Championships; look ahead to sections - Crow River Media [Last Updated On: August 18th, 2024] [Originally Added On: February 12th, 2020]
- Lifespan: The New Science Behind Anti-Aging and Longevity that Can Help You Live to 100 - Thrive Global [Last Updated On: August 18th, 2024] [Originally Added On: February 19th, 2020]
- Not fasting is killing us, but fasting can hurt us too. Here's what to do. - Mashable [Last Updated On: August 18th, 2024] [Originally Added On: February 21st, 2020]
- Anti-Aging Researcher David Sinclair Takes Metformin, NMN ... [Last Updated On: August 18th, 2024] [Originally Added On: February 22nd, 2020]
- Movers and Shakers Week Ending 2.28.20 - milehighcre.com [Last Updated On: August 18th, 2024] [Originally Added On: February 28th, 2020]
- Health inequality in England was bad. It has got worse - The Economist [Last Updated On: August 18th, 2024] [Originally Added On: February 28th, 2020]
- Southland couple join volunteers to help future proof Southland A&P Show - Stuff.co.nz [Last Updated On: August 18th, 2024] [Originally Added On: March 3rd, 2020]
- Pilot Wins Top Honors at Awards Ceremony | Business - Southern Pines Pilot [Last Updated On: August 18th, 2024] [Originally Added On: March 3rd, 2020]
- Flipping the switch on the ageing process - The Age [Last Updated On: August 18th, 2024] [Originally Added On: March 21st, 2020]
- 7 books to read while in coronavirus quarantine or isolation - The CEO Magazine [Last Updated On: August 18th, 2024] [Originally Added On: March 28th, 2020]
- Remembering loved ones who have passed away - the 68 death notices in North Staffordshire this week - Stoke-on-Trent Live [Last Updated On: August 18th, 2024] [Originally Added On: March 31st, 2020]
- Can canine coronavirus drug indomethacin be used in treating humans suffering from COVID-19? - MEAWW [Last Updated On: August 18th, 2024] [Originally Added On: April 11th, 2020]
- Is There Any Legitimate Health Advice in Gwyneth Paltrow's "Goop Lab"? - InsideHook [Last Updated On: August 18th, 2024] [Originally Added On: April 11th, 2020]
- Will Universities, Colleges, And Law School Campuses Be Open In Fall 2020? - Above the Law [Last Updated On: August 18th, 2024] [Originally Added On: April 11th, 2020]
- 'Refreshingly honest' dealer who ran Perth drug den will be sent home to Poland - The Courier [Last Updated On: August 18th, 2024] [Originally Added On: April 14th, 2020]
- Has Harvard's David Sinclair Found the Fountain of Youth? [Last Updated On: August 18th, 2024] [Originally Added On: April 20th, 2020]
- Carole Carson: Adventures in Aging Seven myths about getting older - The Union of Grass Valley [Last Updated On: August 18th, 2024] [Originally Added On: April 25th, 2020]
- Hide and Hedonism invite guests to a virtual wine dinner - Spear's WMS [Last Updated On: August 18th, 2024] [Originally Added On: May 1st, 2020]
- Budget realities from COVID-19 cut $40.6 million from Prince William budgets - Inside NoVA [Last Updated On: August 18th, 2024] [Originally Added On: May 1st, 2020]
- Drug Use is Transmitted from Old to Young - UPJ Athletics [Last Updated On: August 18th, 2024] [Originally Added On: May 16th, 2020]
- Fife woman breached Asbo by having illicit party at home during lockdown - The Courier [Last Updated On: August 18th, 2024] [Originally Added On: May 19th, 2020]
- Jennifer Aniston: How The Morning Show felt like 20 years of therapy - The Detroit News [Last Updated On: August 18th, 2024] [Originally Added On: August 26th, 2020]
- Woods, Waters, and Wildlife: Buy Licenses Now! | FCT News - Freestonecountytimesonline [Last Updated On: August 18th, 2024] [Originally Added On: August 29th, 2020]
- Editorial: Five Birdies That Signal Good Work | Opinion | thepilot.com - Southern Pines Pilot [Last Updated On: August 18th, 2024] [Originally Added On: September 3rd, 2020]
- We all suffer when COVID-19 locks the elderly out of societal participation - The Investment Observer [Last Updated On: August 18th, 2024] [Originally Added On: September 18th, 2020]
- Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and... [Last Updated On: August 18th, 2024] [Originally Added On: September 26th, 2020]
- DS4 to rock Morden live at The Sound Lounge - Your Local Guardian [Last Updated On: August 18th, 2024] [Originally Added On: September 26th, 2020]
- How newly unemployed over-50s can start-up again - The Guardian [Last Updated On: August 18th, 2024] [Originally Added On: October 8th, 2020]
- 100 years old will be the new 60 | Health & Wellness - CL Charlotte [Last Updated On: August 18th, 2024] [Originally Added On: October 16th, 2020]
- Brexit casts doubt over UK pension rights - Interactive Investor [Last Updated On: August 18th, 2024] [Originally Added On: October 16th, 2020]
- Cancer. How close are we to winning the war? - Switzer [Last Updated On: August 18th, 2024] [Originally Added On: October 16th, 2020]
- Where Sabrina the Teenage Witch cast are now - hit TV shows and unrecognisable star - Mirror Online [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Caledonian Braves can 'breathe a bit easier' after first win says boss Ricky Waddell - MSN UK [Last Updated On: August 18th, 2024] [Originally Added On: October 28th, 2020]
- Why Aren't We Talking More About Nutrition Amid COVID-19? - Anti Aging News [Last Updated On: August 18th, 2024] [Originally Added On: November 2nd, 2020]
- We should allow ourselves to be #pharmaproud - - pharmaphorum [Last Updated On: August 18th, 2024] [Originally Added On: November 19th, 2020]
- 6 Anti Aging Benefits of Metformin - The Shepherd of the Hills Gazette [Last Updated On: August 18th, 2024] [Originally Added On: November 19th, 2020]
- Hokitika father charged with murder initially claimed son fell out of bed - Stuff.co.nz [Last Updated On: August 18th, 2024] [Originally Added On: November 19th, 2020]
- Scientists Uncover Approach That Could Reverse Age-Related Vision Loss - Science Times [Last Updated On: August 18th, 2024] [Originally Added On: December 6th, 2020]
- HTLS 2020: A pill that can reverse ageing? Yes, it will be possible, says Dr Sinclair - Hindustan Times [Last Updated On: August 18th, 2024] [Originally Added On: December 6th, 2020]
- Reversing vision loss by turning back the aging clock - FierceBiotech [Last Updated On: August 18th, 2024] [Originally Added On: December 6th, 2020]
- Pill to reverse ageing in 30 years? Why not, says Harvard professor Dr David Sinclair - Hindustan Times [Last Updated On: August 18th, 2024] [Originally Added On: December 6th, 2020]
- Get younger reverse ageing and increase your health span - Have a Go News [Last Updated On: August 18th, 2024] [Originally Added On: December 8th, 2020]
- Over 50s Spending Spree Boosts Economy By Billions - Money International [Last Updated On: August 18th, 2024] [Originally Added On: January 20th, 2021]
- Hunger in Milwaukee and the World: What We Can Do About It - Wisconsin Public Radio News [Last Updated On: August 18th, 2024] [Originally Added On: February 15th, 2021]
- Woman's 'nasty' skin infection most likely caused by swimming in sea after shaving legs - Stuff.co.nz [Last Updated On: August 18th, 2024] [Originally Added On: August 3rd, 2021]
- David Sinclair | The Sinclair Lab [Last Updated On: August 18th, 2024] [Originally Added On: December 21st, 2021]
- David Sinclair Supplements List Deep Dive - Updated 2021 [Last Updated On: August 18th, 2024] [Originally Added On: December 21st, 2021]
- Don't Listen to Intermittent Fasting Influencers, The Science Doesn't Back It Up - InsideHook [Last Updated On: August 18th, 2024] [Originally Added On: April 27th, 2022]
- David Sinclair Post-2022 Canyons by UTMB 100k Interview - iRunFar [Last Updated On: August 18th, 2024] [Originally Added On: April 27th, 2022]
- Authorized Biography Of The Rolling Stones Charlie Watts Launched In London - uDiscover Music [Last Updated On: August 18th, 2024] [Originally Added On: September 24th, 2022]
- David Sinclair Supplements (2022 List) | Brands for Anti-Aging! [Last Updated On: August 18th, 2024] [Originally Added On: September 24th, 2022]